The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis

D Inzitari1, A Di Carlo, M Mascalchi

  • 1Department of Neurological and Psychiatric Sciences, University of Florence, Italy.

Insights

Patients with motor impairment and extensive leukoaraiosis face a significantly higher risk of stroke and cardiovascular events. Lacunar infarction appears to be a key factor influencing their poor long-term outcome.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Radiology

Background:

  • The long-term prognosis for patients exhibiting motor impairment and extensive leukoaraiosis on computed tomographic scans remains largely unknown.
  • Leukoaraiosis, a white matter change, is often associated with cerebrovascular disease.

Purpose of the Study:

  • To investigate the incidence of stroke, myocardial infarction, and death in patients with motor impairment and extensive leukoaraiosis.
  • To compare the cardiovascular outcomes of these patients against a control group without leukoaraiosis.

Main Methods:

  • A cohort study involving 31 patients with motor impairment and extensive leukoaraiosis (cases) and 68 neurologic patients without leukoaraiosis (controls).
  • Both groups underwent routine neurologic and cardiovascular assessments.
  • Follow-up duration averaged approximately 50 months for both cases and controls.

Main Results:

  • The 6-year cumulative risk of stroke was significantly higher in cases (49%) compared to controls (16%), with a hazard ratio of 3.0.
  • The combined risk of stroke or myocardial infarction was also substantially greater in cases (69%) versus controls (36%), hazard ratio 2.9.
  • Adjusting for conventional vascular risk factors did not eliminate the increased stroke risk in cases, but adjustment for lacunar stroke history and imaging reduced the observed risk.

Conclusions:

  • Patients presenting with motor impairment and extensive leukoaraiosis experience a markedly poor cardiovascular outcome.
  • The presence of lacunar infarction may be a primary determinant of the adverse long-term prognosis in this patient population.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...